In hepatocellular carcinoma, for example, NTPDase2 promotes tumor growth and the maintenance of myeloid-derived suppressor cells, allowing cancer cells to escape immune surveillance by suppressing T cells in mice [36]. Here, ENTPD2 is linked to hepatocellular carcinoma.